BSECompany Update3d ago · 22 Sept 2026, 12:23 pm
Intimation Under Regulation 30 of SEBI (LODR) Regulations, 2015, Receipt of Significant International Purchase Order.
Shelter Pharma Ltd · 543963
✦ AI Summary▲ PositiveOrder Win
Shelter Pharma Ltd has received a significant international purchase order from Berlin International Company for the supply of nutraceutical products, valued at USD 10,150. This order is expected to have a positive impact on the company's business performance and revenue growth.
Analysis Scores
Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Attachments (1)
📄pdf
Download →
9a95ce71-9ef1-4d31-aced-3def29959020.pdf
View document text
Date: 22nd September, 2026
BSE Limited,
Floor 25, P J Towers,
Dalal Street, Mumbai – 400001
Scrip ID: SHELTER
Scrip Code: 543963
Subject: Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 ––
Receipt of Significant International Purchase Orders.
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI read with Schedule III (Listing Obligations
and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the
Company has received export order from Berlin International Company in the
normal course of business.
The receipt of this export order is in line with the Company's strategic focus on
diversifying its revenue base and strengthening its presence in international
markets. This is expected to have a positive impact on the Company's overall
business performance.
The receipt of this order marks a positive development for Shelter Pharma Limited
as the Company continues to broaden its market reach across the global
nutraceutical sector. Supported by its research and development capabilities,
enables the Company to develop and offer products in line with evolving market and
customer requirements. The order is expected to contribute to the Company’s
business and revenue growth upon execution and further expand its international
customer base. The association with an overseas customer also provides an
opportunity for Shelter Pharma to make use of its R&D expertise to develop and
offer innovative products suited to international market requirements. The
Company will continue to focus on research and development, product quality and
timely execution while exploring opportunities to further expand its presence across
global nutraceutical and healthcare markets.
The details pursuant to SEBI Listing Regulations, 2015 and SEBI Master Circular
No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is
mentioned in the Annexure A.
Kindly take the above information on record.
Thanking You,
FOR SHELTER PHARMA LIMITED
MUSTAQIM NISARAHMED SABUGAR
MANAGING DIRECTOR
DIN: 01456841
Place: Ahmedabad
Annexure - A
Details pursuant to Regulation 30 of SEBI Listing Regulations, 2015 and SEBI
Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated
30th January, 2026
Sr. Particulars Details
1 Name of the entity awarding the order Berlin International Company
2 Significant terms and conditions of The Company has received purchase
order awarded in brief orders for supply of Nutraceutical
products namely:
D3 CURE 50 ML
Qty 3500x2.90 – (USD
10,150)
3 Whether order have been awarded by International Entity
domestic/ international entity
4 Nature of order; Normal course of business
5 Whether domestic or international International
6 Time period by which the order is to The order is to be executed within the
be executed mutually agreed timelines as per
purchase order schedule.
7 Broad consideration or size of the USD 10,150 or Rs. 9,72,360.86
order (Rupees Nine Lakhs Seventy-Two
Thousand Three Hundred and Sixty
and Eighty-Six Paise only)
8 Whether the promoter/ promoter No, the promoter / promoter group /
group / group companies have any group companies do not have any
interest in the entity that awarded the interest in the entity.
order? If yes, nature of interest and
details thereof
9 Whether the order would fall within No, the transaction does not fall under
related party transactions? related party transactions.